EQUINIX, INC. $75,000,000 2.50% Convertible Subordinated Debentures due 2024 PURCHASE AGREEMENTPurchase Agreement • May 6th, 2004 • Equinix Inc • Telephone communications (no radiotelephone) • New York
Contract Type FiledMay 6th, 2004 Company Industry Jurisdiction
CV THERAPEUTICS, INC. $100,000,000 2.0% Senior Subordinated Convertible Debentures Due 2023 PURCHASE AGREEMENTPurchase Agreement • August 14th, 2003 • Cv Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 14th, 2003 Company Industry Jurisdictiondant or respondent, nor am I aware of any adverse judgment, decree or order currently in effect that has been issued by the FDA against the Company